Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 9 | 9 | 20 | 10 | 0 |
| Gross Profit | 9 | 9 | 20 | 10 | N/A |
| Operating Expenses | 15,336 | 12,855 | 10,696 | 9,747 | 8,662 |
| Operating Income | -15,327 | -12,846 | -10,686 | -9,737 | -8,652 |
| Interest Expense | 1,093 | 349 | 391 | 430 | 495 |
| Other Income | 331 | 315 | 251 | 214 | 71 |
| Pre-tax Income | -16,089 | -12,880 | -10,826 | -9,953 | -9,076 |
| Net Income Continuous | -16,089 | -12,880 | -10,827 | -9,953 | -9,076 |
| Net Income | $-16,089 | $-12,880 | $-10,827 | $-9,953 | $-9,076 |
| EPS Basic Total Ops | -303.60 | -243.63 | 940.78 | -187.41 | -209.90 |
| EPS Basic Continuous Ops | -302.70 | -242.52 | 937.95 | -188.32 | -208.30 |
| EPS Diluted Total Ops | -303.60 | -243.63 | 940.78 | -187.41 | -209.90 |
| EPS Diluted Continuous Ops | -302.70 | -242.52 | 937.95 | -188.32 | -208.30 |
| EBITDA(a) | $-15,240 | $-12,797 | $-10,593 | $-9,661 | $-8,614 |